- Menopause is confirmed
- After 12 months without a period
- Typical age
- 45 to 55
- With a uterus
- Estrogen needs a progestogen for endometrial protection
- Vaginal symptoms
- Often respond to low-dose local estrogen
Where you might be starting from
Most people arrive at this topic from one of three places. Some have new symptoms and want to know whether hormones are the explanation. Some want a baseline set of labs before deciding anything. Others already suspect they want hormone therapy and need to know whether it is a reasonable choice for them.
All three paths meet at the same place: a careful history. Your cycle pattern, the symptoms that bother you most, your personal and family medical history and your own preferences matter more than any single number on a lab report.
Why one blood test rarely settles perimenopause
During perimenopause, ovarian hormones do not decline in a smooth line. Estradiol and FSH can swing from high to low within the same month, so a single draw may look entirely ordinary on a day you feel awful. For that reason, clinicians usually identify perimenopause from age, changes in cycle length or flow, and symptoms.
Menopause itself is defined in hindsight: it is the point 12 months after your final period. Most women reach it between 45 and 55. Menopause before 45 is considered early and before 40 is considered premature, and both deserve a closer medical look.
Labs still earn their place. They help rule out conditions that mimic the transition, such as thyroid disease, iron deficiency, anemia or low B12, and they give a baseline for lipids, glucose and other markers that tend to shift in midlife.
The symptoms that come with the transition
Hot flashes and night sweats are the best-known symptoms, but they are far from the only ones. Many women notice broken sleep, a shorter fuse or new anxiety, trouble finding words, joint aches, dry skin, changes in hair, bloating and a shift of weight toward the abdomen.
Genitourinary symptoms deserve their own mention. Vaginal dryness, pain with sex, urinary urgency and repeat urinary tract infections are part of the genitourinary syndrome of menopause. Unlike hot flashes, these tend to persist or worsen over time if untreated.
- Vasomotor: hot flashes, night sweats, flushing
- Sleep: waking at 3 or 4 a.m., trouble falling back asleep
- Mood and thinking: irritability, anxiety, brain fog
- Body: joint pain, palpitations, headaches, skin and hair changes
- Genitourinary: dryness, painful sex, urgency, recurrent UTIs
How a decision about hormone therapy is made
There is no lab threshold that triggers treatment. A clinician weighs how much your symptoms affect daily life, how long it has been since your last period, your age, your cardiovascular, clot and breast cancer history, and whether non-hormonal options might suit you better.
The Menopause Society's position is that for healthy women younger than 60 or within 10 years of menopause who have bothersome symptoms, the benefit-risk balance of hormone therapy is generally favorable. Starting later, or with existing heart disease, clot history or certain cancers, shifts that balance and calls for a more careful conversation.
Non-hormonal choices exist as well, including certain prescription medicines for hot flashes and cognitive behavioral approaches for sleep. A good visit puts those on the table instead of treating hormones as the only answer.
What the risk evidence actually says
Much of the fear around hormone therapy traces back to the Women's Health Initiative, published in 2002. Its headline findings were reported mostly as relative risks, and the average participant was in her 60s, often many years past menopause. Later analyses showed that age and time since menopause change the picture considerably, and the estrogen-alone arm, in women without a uterus, produced different results from the combined arm.
Labeling has caught up with that evidence. In February 2026, FDA approved labeling changes that removed statements about cardiovascular disease, breast cancer and probable dementia from the boxed warning on several menopausal hormone therapy products, including vaginal estrogen. The prescribing information still describes the benefits and risks in detail.
Risks have not disappeared. Oral estrogen raises the risk of blood clots and stroke, combined therapy is associated with a small increase in breast cancer risk with longer use, and anyone with a history of clots, stroke, heart disease or a hormone-sensitive cancer needs an individualized discussion.
Pills, patches, gels and creams
How estrogen enters your body changes how it behaves. Oral estrogen passes through the liver first, which affects clotting factors and other proteins. Transdermal estrogen, delivered by patch, gel or cream, largely bypasses that first pass, and observational data suggest a lower risk of blood clots compared with oral forms.
Route choice also depends on practical things: skin reactions, how reliably you will apply a gel, whether you prefer a twice-weekly patch, and cost. Your clinician should explain why a particular route fits you.
Why progesterone comes with estrogen if you have a uterus
Estrogen on its own stimulates the lining of the uterus, and over time unopposed estrogen raises the risk of endometrial hyperplasia and cancer. If you still have a uterus, a progestogen is added to protect the lining. If you have had a hysterectomy, estrogen alone is usually used.
Not all progestogens are the same. Micronized progesterone is chemically identical to the hormone your ovaries make, while synthetic progestins differ in structure and in some of their effects. Some women also find oral progesterone helps them sleep. Unexpected bleeding on therapy should always be reported.
Treating vaginal and urinary symptoms
Low-dose vaginal estrogen, in cream, tablet or ring form, acts mainly on local tissue and is effective for dryness, painful sex and some urinary symptoms. Because so little reaches the bloodstream, it is often an option even for women who do not want or cannot take systemic therapy, though anyone with a history of breast cancer should decide with her oncology team.
What hormone therapy will not do
HRT is not a weight-loss treatment, though better sleep can make healthy habits easier. It is not a treatment for clinical depression, and it is not approved to prevent dementia or heart disease. It also works on different timelines for different symptoms: hot flashes often ease within weeks, while vaginal tissue changes can take a few months.
How long to stay on it
There is no automatic stop date. Current guidance favors reviewing benefits and risks at least once a year and continuing as long as the benefits clearly outweigh the risks for you. When you do stop, tapering versus stopping at once is a choice to make with your clinician, and some symptoms may return.
How care works at HealifyMD
You start with a free online eligibility check, then meet a licensed clinician by video or online visit. If hormone therapy is appropriate, your plan may include estradiol and progesterone, and medication is shipped from a licensed U.S. pharmacy. Some products are compounded; compounded hormones are not FDA-approved and are not the same as FDA-approved brand products, so ask why a compounded form is being chosen for you.
The hormone therapy program is listed at $349 for the first month, which includes your evaluation and baseline labs, then $99 per month; other labs are priced separately. Prices are confirmed during your eligibility review, and there is no membership fee.
Common questions
Can a blood test confirm I am in perimenopause?
Usually not on its own. Hormone levels fluctuate so much during the transition that a single result can be misleading, so diagnosis rests mainly on age, cycle changes and symptoms.
Does hormone therapy cause breast cancer?
Combined estrogen plus progestogen is linked to a small increase in risk with longer use, while estrogen alone in women without a uterus behaves differently. Your personal and family history shape what that means for you.
Is a patch safer than a pill?
Transdermal estrogen avoids the first pass through the liver and is associated with a lower clot risk than oral estrogen in observational studies. It is often preferred for women with clot or migraine concerns.
I had a hysterectomy. Do I need progesterone?
Usually not, since the main reason for adding a progestogen is to protect the uterine lining. There are exceptions, such as a history of endometriosis, so confirm with your clinician.
Is it too late to start at 62?
Not automatically. Starting more than 10 years after menopause or after 60 changes the balance of risks, so it requires a more detailed review, and transdermal or vaginal options may be considered.
Will vaginal dryness go away by itself?
It usually does not. These tissue changes tend to progress, but they often respond well to low-dose vaginal estrogen or other local treatments.
Are compounded bioidentical hormones safer?
There is no good evidence that they are. The National Academies recommended limiting compounded hormones to people who cannot use an FDA-approved product, such as those with an ingredient allergy.
Sources
We cite government agencies, professional societies and peer-reviewed research. See our editorial policy.
- MenopauseMedlinePlus (National Library of Medicine)
- The 2022 hormone therapy position statement of The North American Menopause SocietyThe Menopause Society (PubMed)
- FDA approves labeling changes for menopausal hormone therapy productsU.S. Food and Drug Administration
- Prescribers should restrict the use of non-FDA-approved compounded bioidentical hormones except for specific medical circumstancesNational Academies of Sciences, Engineering, and Medicine
- Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration